GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (XTAE:CANF) » Definitions » E10

Can Fite Biofarma (XTAE:CANF) E10 : ₪-0.72 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Can Fite Biofarma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Can Fite Biofarma's adjusted earnings per share data for the three months ended in Dec. 2023 was ₪-0.019. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₪-0.72 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-16), Can Fite Biofarma's current stock price is ₪0.027. Can Fite Biofarma's E10 for the quarter that ended in Dec. 2023 was ₪-0.72. Can Fite Biofarma's Shiller PE Ratio of today is .


Can Fite Biofarma E10 Historical Data

The historical data trend for Can Fite Biofarma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma E10 Chart

Can Fite Biofarma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -2.30 - -0.72

Can Fite Biofarma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.94 -0.88 -0.84 -0.72

Competitive Comparison of Can Fite Biofarma's E10

For the Biotechnology subindustry, Can Fite Biofarma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Can Fite Biofarma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Can Fite Biofarma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Can Fite Biofarma's Shiller PE Ratio falls into.



Can Fite Biofarma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Can Fite Biofarma's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.019/129.4194*129.4194
=-0.019

Current CPI (Dec. 2023) = 129.4194.

Can Fite Biofarma Quarterly Data

per share eps CPI Adj_EPS
201403 -0.390 99.695 -0.506
201406 -0.373 100.560 -0.480
201409 -0.188 100.428 -0.242
201412 -0.328 99.070 -0.428
201503 -0.056 99.621 -0.073
201506 -0.305 100.684 -0.392
201509 -0.512 100.392 -0.660
201512 0.108 99.792 0.140
201603 -0.205 100.470 -0.264
201606 -0.178 101.688 -0.227
201609 -0.305 101.861 -0.388
201612 -0.419 101.863 -0.532
201703 -0.184 102.862 -0.232
201706 -0.184 103.349 -0.230
201709 -0.147 104.136 -0.183
201712 -0.184 104.011 -0.229
201803 -0.184 105.290 -0.226
201806 -0.111 106.317 -0.135
201809 0.000 106.507 0.000
201812 -0.332 105.998 -0.405
201903 -0.147 107.251 -0.177
201906 -0.113 108.070 -0.135
201909 -0.091 108.329 -0.109
201912 -0.111 108.420 -0.132
202003 -0.111 108.902 -0.132
202006 -0.035 108.767 -0.042
202009 -0.021 109.815 -0.025
202012 0.000 109.897 0.000
202103 -0.014 111.754 -0.016
202106 -0.023 114.631 -0.026
202109 -0.037 115.734 -0.041
202112 -0.037 117.630 -0.041
202203 -0.011 121.301 -0.012
202206 -0.010 125.017 -0.010
202209 -0.016 125.227 -0.017
202212 0.000 125.222 0.000
202303 -0.008 127.348 -0.008
202306 -0.005 128.729 -0.005
202309 -0.005 129.860 -0.005
202312 -0.019 129.419 -0.019

Add all the adjusted EPS together and divide 10 will get our e10.


Can Fite Biofarma  (XTAE:CANF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Can Fite Biofarma E10 Related Terms

Thank you for viewing the detailed overview of Can Fite Biofarma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Can Fite Biofarma (XTAE:CANF) Business Description

Traded in Other Exchanges
Address
10 Bareket Street, Kiryat Matalon, P.O. Box 7537, Petah-Tikva, ISR, 4951778
Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

Can Fite Biofarma (XTAE:CANF) Headlines

From GuruFocus

Can-Fite BioPharma Announces $6 Million Registered Direct Offering

By Marketwired Marketwired 05-20-2019